26
Henlius
2696.HK·HKEXShanghai CNFounded 20103,000 employees
Mid CapbiotechPublicOncologyImmunology
Platform: Biosimilar
Market Cap
$2B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (2696.HK)
Loading 2696.HK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 269-6259 | 269-6259 | Phase 3 | 2 | PCSK9 | SCLCACC | ||
| 269-7185 | 269-7185 | Preclinical | 1 | SOS1 | Ewing SarcomaPNH |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
Henlius trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)